Vulnerability Description
Multiple cross-site scripting (XSS) vulnerabilities in Canon Medical Vitrea View 7.x before 7.7.6 allow remote attackers to inject arbitrary web script or HTML via (1) the input after the error subdirectory to the /vitrea-view/error/ subdirectory, or the (2) groupID, (3) offset, or (4) limit parameter to an Administrative Panel (Group and Users) page. There is a risk of an attacker retrieving patient information.
CVSS Score
MEDIUM
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Canon | Medical Vitrea View | >= 7.0, < 7.7.6 |
Related Weaknesses (CWE)
References
- https://www.trustwave.com/en-us/resources/security-resources/security-advisoriesExploitThird Party Advisory
- https://www.vitalimages.com/customer-success-support-program/vital-images-softwaVendor Advisory
- https://www.vitalimages.com/vitrea-vision/vitrea-view/ProductVendor Advisory
- https://www.trustwave.com/en-us/resources/security-resources/security-advisoriesExploitThird Party Advisory
- https://www.vitalimages.com/customer-success-support-program/vital-images-softwaVendor Advisory
- https://www.vitalimages.com/vitrea-vision/vitrea-view/ProductVendor Advisory
FAQ
What is CVE-2022-37461?
CVE-2022-37461 is a vulnerability with a CVSS score of 6.1 (MEDIUM). Multiple cross-site scripting (XSS) vulnerabilities in Canon Medical Vitrea View 7.x before 7.7.6 allow remote attackers to inject arbitrary web script or HTML via (1) the input after the error subdir...
How severe is CVE-2022-37461?
CVE-2022-37461 has been rated MEDIUM with a CVSS base score of 6.1/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2022-37461?
Check the references section above for vendor advisories and patch information. Affected products include: Canon Medical Vitrea View.